Aims/hypothesis Fasting and exercise are strong physiological stimuli for hepatic glucose production. IL-6 has been implicated in the regulation of gluconeogenic genes, but the results are contradictory and the relevance of IL-6 for fasting-and exercise-induced hepatic glucose production is not clear. Methods Investigations were performed in rat hepatoma cells, and on C57Bl6 and Il6 −/− mice under the following conditions: IL-6 stimulation/injection, non-exhaustive exercise (60 min run on a treadmill) and fasting for 16 h. Metabolite analysis, quantitative real-time PCR and immunoblotting were performed.
Introduction
Hepatic glucose production is essential for the maintenance of glucose homeostasis and for glucose supply to other tissues. Glycogen breakdown contributes substantially to hepatic glucose delivery, but glycogen stores are limited and de novo synthesis of glucose from gluconeogenic precursors is necessary for systemic fuel availability during an overnight fast or under conditions of high energy demand such as prolonged physical activity [1] [2] [3] . Gluconeogenesis is mainly controlled by the activity of the key enzymes glucose 6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK). Expression of the genes encoding the above is under tight control of insulin and glucagon. IL-6 has also been implicated in the regulation of these genes. Studies using cultured rat hepatocytes showed that incubation with IL-6 attenuated glucagon-induced Pepck (also known as Pck1) expression [4] or inhibited dexamethasone/cAMP-induced Pepck and G6pase (also known as G6pc) expression [5] . Intraperitoneal application of IL-6 inhibited the increase in Pepck mRNA during the initial phase of fasting in rats [6] . Mice secreting IL-6 from injected tumours had decreased G6Pase activity and mRNA levels in the liver, while the activity of PEPCK was not affected [7] . The most important downstream signal transducer of IL-6 is signal transducer and activator of transcription 3 (STAT3), the tyrosine phosphorylation of which induces dimerisation and activation of IL-6 [8] . Mice with a liver-specific STAT3 deficiency had increased levels of gluconeogenic enzymes, while liverspecific production of a constitutively active form of STAT3 repressed their transcription [5] . Further studies revealed that STAT3 targeted the regulatory promoter regions of gluconeogenic genes in vivo [9] . While these data clearly point to an inhibitory effect of IL-6 on hepatic glucose production, other studies have shown stimulation of gluconeogenesis by IL-6 in rat hepatocytes [10] and transcriptional upregulation of the G6pase promoter by IL-6-mediated activation of STAT3 [11] . Furthermore, IL-6 could increase hepatic glucose release, since it stimulated glycogenolysis in rat hepatocytes [12, 13] ; more importantly, subcutaneous IL-6 administration in humans resulted in higher plasma glucose levels [14] . From these contradictory results, we hypothesised that IL-6 has the ability to regulate hepatic glucose production, but that the specific outcome depends on superior regulatory mechanisms such as the action of insulin and glucagon, and the presence of further regulatory hormones and cytokines.
Two relevant physiological situations with a special need for hepatic glucose output are fasting and prolonged exercise. It has been suggested that exercise-induced IL-6 production and release from the working muscle, leading to elevated IL-6 plasma levels [15, 16] , might enhance hepatic glucose production during exercise [17] . Il6 −/− mice had lower endurance capacity shown as time till exhaustion on a treadmill, possibly explained by impaired hepatic glucose production [18] . However, a direct effect of exerciseinduced IL-6 production on hepatic metabolism has yet to be demonstrated. Moreover it is unclear whether IL-6-dependent signal transduction in the liver is important during fasting.
Here we used Il6 −/− mice to study the regulation of hepatic glucose production, expression of gluconeogenic regulators and hepatic IL-6 signalling during fasting and moderately intense exercise in the absence of IL-6. We also studied the direct effect of IL-6 on glucose production from lactate in rat hepatoma cells, as well as the direct effect of IL-6 on expression of Pepck and G6pase in the liver of wild-type mice. Our data revealed that IL-6 is able to stimulate glucose production from lactate in vitro and to increase hepatic Pepck expression in mice, but is dispensable for fasting-or moderate exercise-induced glucose production in Il6 −/− mice.
Methods
Materials Fao rat hepatoma cells were from the European Collection of Cell Cultures (http://www.hpacultures.org.uk/ products/celllines/index.jsp). Recombinant mouse and rat IL-6 was from R&D Systems (Wiesbaden-Nordenstadt, Germany). DL-lactate, dexamethasone and 8-(4-chlorophenylthio)adenosine 3′,5′-cyclic monophosphate sodium salt (8-CPT-cAMP) were from Sigma (Munich, Germany). Cell culture media and supplements were from Lonza (Basel, Switzerland). Cell proliferation reagent WST-1 was from Roche (Mannheim, Germany). The antibody against PEPCK was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against phospho-STAT3 Tyr 705, STAT3 and β-actin were from Cell Signaling Technology (Frankfurt, Germany). The IRS-2 protein antibody was from Millipore (Schwalbach, Germany).
Cell culture Fao cells were kept in RPMI 1640 medium supplemented with 10% (vol./vol.) FCS, 100 U/ml penicillin and 100 µg/ml streptomycin. For experiments the cells were starved overnight in a serum-and glucose-free medium containing 2 mmol/l DL-lactate. On the following day cells were treated with 20 ng/ml IL-6, 0.1 μmol/l dexamethasone and 0.1 mmol/l 8-CPT-cAMP in glucose-and serum-free medium containing 10 mmol/l DL-lactate for 5 and 24 h respectively.
Animal care All animal experiments were conducted in accordance with the guidelines for laboratory animal care and were approved by the local governmental commission for animal research (Regierungspraesidium). Male C57Bl/6J mice and Il6 −/− (B6.129S2-Il6 tmlKopf /J) mice maintained on a C57Bl/6J-background were purchased from Jackson Laboratory (Bar Harbor, ME, USA) and kept under an inverted light-dark cycle (dark period 09:30-21:30 hours, light period 21:30-09:30 hours) with free access to standard chow (Sniff, Soest, Germany) and tap water.
For acute IL-6 application, a bolus of IL-6 (2 μg/kg) was injected intraperitoneally in non-fasted 12-week-old male C57Bl/6 mice. For fasting experiments, 11-to 14-week-old mice were either fasted over 16 h or had free access to standard lab animal chow.
Exercise experiments were performed between 10:00 and 14:00 hours. Mice (12-week-old) habituated to treadmill running on a treadmill with motorised grade adjustment (Mouse Accupacer; Hugo Sachs Elektronik, March-Hugstetten, Germany) ran for 60 min at 14 m/min and 14°inclination after 5 min warm-up (5 m/min at 5°i nclination). Mice attempting to rest were encouraged to continue running by gently tapping on their back. Mice in the sedentary group had no access to food for the last 60 min before being killed. Exercised animals were killed immediately after running. All animals were anaesthetised with an intraperitoneal injection of ketamine (150 mg/kg body weight) and xylazine (10 mg/kg body weight) and killed by decapitation. Liver tissues were immediately removed and frozen in liquid nitrogen or directly processed for protein analysis.
Blood variables Non-esterified fatty acids, triacylglycerol and hormones were measured in the EDTA-plasma collected after decapitation. NEFA and triacylglycerol concentrations were detected by a fully automatic enzymatic method on a multi analyser (ADVIA 1650; Siemens Health Care Sector, Fernwald, Germany). Insulin and glucagon levels were measured by radio-immunoassay (Linco Research, St Charles, MO, USA), and IL-6 and leptin by a kit (mouse Luminex; Linco Research). Glucose was quantified in capillary blood samples taken from the tail vein using a glucometer (Accu-Chek Aviva; Roche, Mannheim, Germany). For the glucose tolerance test, mice were fasted for 16 h prior to i.p. injection of glucose (2 mg/g body weight). For the insulin tolerance test, mice had free access to chow prior to i.p. injection of 0.5 mU insulin/g body weight (Insuman rapid; sanofi-aventis, Frankfurt am Main, Germany). Blood glucose levels were determined at the indicated time points following respective injections.
Cell/ tissue lysis and western blotting Cells were lysed in 175 μl per well of lysis buffer (50 mmol/l HEPES, pH 7.5; 150 mmol/l NaCl; 1.5 mmol/l MgCl 2 ; 1 mmol/l EDTA; 10% (vol./vol.) glycerin; 1% (vol./vol.) Triton X-100) containing protease and phosphatase inhibitors. Protein (250 µg) of total extracts was separated by SDS-PAGE (7.5%, vol./vol.) and western blot analysis was performed as described elsewhere [19] .
Liver tissue aliquots were immediately homogenised at 4°C in lysis buffer (50 mmol/l TRIS, 150 mmol/l NaCl, 1% [vol./vol.] Triton X-100) containing protease inhibitor (Complete; Roche) and phosphatase inhibitors. Homogenates were allowed to solubilise for 30 min on ice and were then clarified by three subsequent centrifugation steps at 13,000×g for 15 min. For detection of protein levels and phosphorylation, 150 μg of total protein were used.
Gene expression Frozen liver tissue was homogenised in a device (TissueLyser; Qiagen, Hilden, Germany) and total RNA was extracted using a kit (RNeasy mini; Qiagen) according to the manufacturer's instructions. Total RNA from Fao cells was also extracted using the same kit. For reverse transcription PCR, 1 μg of RNA was used with random hexamer primers and a cDNA synthesis kit (Transcriptor First Strand; Roche) according to the manufacturer's instructions. RNA expression was measured by real-time quantitative PCR on the Light Cycler 480 System (Roche) using kits (FastStart DNA-MasterSYBR Green I; Roche; or QuantiFast SYBR Green PCR Kit; Qiagen). The primer sets used and cycling conditions are described in the Electronic supplementary material (ESM) Table 1 . The mRNA content is given in arbitrary units. Normalisation to β-actin mRNA content generated results comparable to non-normalised values.
Glycogen content Glycogen levels were determined by a modification of the procedure described by Chan and Exton [20] . Liver tissue was weighted and solubilised for 10 min with 250 µl 30% KOH at 90°C. Glycogen was precipitated by centrifugation (30 min at 10,000×g and 4°C) after adding 0.2 volumes 1 mol/l Na 2 SO 4 and three volumes 100% ice-cold ethanol. The precipitate was washed twice with 70% ethanol, dried and then hydrolysed for 1 h with 250 µl 1 mol/l HCl at 90°C. After neutralisation with 1 mol/l NaOH, glucose was determined enzymatically (ADVIA 1650; Siemens Health Care).
Statistical analysis Means ± SEM were calculated and groups of data were compared using Student's t test and a statistical software package (JMP 4.0; SAS Institute, Cary, NC, USA). Statistical significance was set at p<0.05.
Results
Effect of IL-6 on glucose production of Fao hepatoma cells First we studied the effect of IL-6 on glucose production and expression of gluconeogenic enzyme genes Pepck and G6pase in rat hepatoma cells. This cell line is able to produce glucose from gluconeogenic precursors and release glucose into the supernatant fraction. Providing lactate to the cells induced production of considerable amounts of glucose after 5 h (Fig. 1a ) and 24 h (Fig. 1b) , this process being enhanced by dexamethasone, a wellknown stimulator of gluconeogenesis (Fig. 1a, b) , and reduced by insulin (data not shown). The presence of IL-6 resulted in a significantly higher rate of glucose production than with lactate alone after 5 h and 24 h (Fig. 1a, b ). We were unable to detect a considerable effect of IL-6 on glucose release in the absence of lactate, arguing against stimulation of glycogenolysis as a source of glucose in our experiments (data not shown). Despite that effect on glucose production, the expression of Pepck and G6pase mRNA was not influenced by treatment with IL-6. Expression levels of both enzymes were strongly increased after 24 h by addition of lactate, and to a lesser extent after 5 h, without any further effect of IL-6 ( Fig. 1c-f) , while the combination of dexamethasone and cAMP (given as cellpermeable 8-CPT-cAMP) had a strong additive effect. However, under these conditions IL-6 stimulation increased phosphorylation of STAT3 (Fig. 1g) and expression of Socs3 ( Fig. 1h; p=0 .08 IL-6 vs lactate alone), which demonstrated activation of IL-6-dependent gene expression. We also observed a significant decrease of Socs3 expression by dexamethasone/cAMP (Fig. 1h ), but this was not further evaluated in this study. The viability of the cells was not affected in the presence of IL-6 as determined by WSTassay (103±18% vs 100% viability of cells cultured in 10 mmol/l lactate; data not shown). Effect of acute IL-6 application on hepatic expression of Pepck and G6pase in mice To exclude the possibility that we had missed an effect of IL-6 on expression of gluconeogenic enzyme genes due to limitations of the Fao cell culture model, we injected mice with IL-6 (2 μg/kg) intraperitoneally and studied hepatic gene expression after 30 and 60 min of treatment. IL-6 plasma levels were strongly increased after 30 and 60 min of injection, but still in a range achieved by intense exercise (55±10 and 60± 9 pg/ml, respectively; Fig. 2a ). Pepck expression was slightly elevated by IL-6 after both time points, while no increase was detected for G6pase (Fig. 2b, c) . Pronounced upregulation of the IL-6 target gene Socs3 was found (Fig. 2d) , indicating that the treatment with IL-6 induced a strong effect on genes with IL-6-dependent regulation.
IL-6 deficiency of mice does not impair fasting-induced glucose production, but results in higher glucose levels in the fed state The data obtained in Fao cells and IL-6-treated mice indicated that IL-6 could be involved in the induction of gluconeogenesis. To test the relevance of IL-6 in vivo, we compared wild-type and Il6 −/− mice in two physiological situations when hepatic glucose production is needed to provide fuels for other organs, namely during fasting and endurance exercise. First we studied the response to a 16 hfast. As shown in Fig. 3a-d , both genotypes responded to fasting with a decrease in plasma glucose, plasma insulin and plasma triacylglycerol concentrations, and an increase in plasma NEFA levels without any detectable betweengroup difference. The only observed significant difference between both genotypes was that plasma glucose levels in the fed state were higher in Il6 −/− mice (Fig. 3a) .
The fasting-induced upregulation of hepatic PEPCK (Fig. 4a ) and IRS-2 protein content (Fig. 4b) , and of Pgc-1α (also known as Ppargc1a) mRNA expression in the liver (Fig. 4c) was similar in wild-type and Il6 −/− mice.
mRNA expression of Pepck, G6pase and Irs2 was not increased comparing the fed with the fasted state, while the immunoblots for G6Pase were inconclusive due to several unspecific bands (data not shown). The only difference between the genotypes was in the fed state, with slightly higher levels of PEPCK in Il6 −/− mice, well in line with the higher plasma glucose levels in these mice when fed. When we studied IL-6-dependent signal transduction under these conditions, we found no indication for its activation by fasting or feeding, either in the form of phosphorylation of STAT3 or changes to Socs3 expression (Fig. 4d, e) .
Phosphorylation of STAT3 was slightly lower in Il6
−/− mice ( Fig. 4d) , but still detectable.
IL-6 deficiency of mice does not impair exercise-induced glucose production
The fact that responses of wild-type and Il6 −/− mice in hepatic glucose production and upregulation of gluconeogenic regulators were comparable does not exclude the possibility that lack of IL-6 may become evident in situations when IL-6 plasma levels would be increased and release of IL-6 into the circulation might fulfil a physiological function, as has been demonstrated during prolonged exercise. Therefore we studied the response of hepatic glucose metabolism to acute exercise after a 60 min treadmill run in wild-type and Il6 −/− mice.
No difference was seen in average body weight between the groups (25.6±1.9 g in wild-type, 25.1±2.3 g in Il6 −/− mice). The exercise conditions allowed running at a moderate intensity, with both genotypes able to complete the run without obvious difficulties. The plasma glucose levels before and after the run did not differ between the genotypes, with an average decrease of 2.42±0.49 mmol/l in wild-type and 2.41±0.43 mmol/l in Il6 −/− mice after running (Fig. 5a ). NEFA were increased to comparable concentrations after running, while sedentary Il6 −/− mice had lower levels than sedentary wild-type mice (486±63 vs 606±59 μmol/l; Fig. 5b ). Plasma insulin levels were higher in sedentary Il6 −/− mice, decreasing after exercise in both genotypes to similar values (Fig. 5c ). No significant difference in plasma glucagon levels was detected (Fig. 5d ), but Il6 −/− mice had a clearly higher insulin/ glucagon ratio in the sedentary state. After exercise, this ratio strongly decreased in both genotypes, resulting in (Fig. 5e ). Hepatic glycogen stores were found to be almost depleted after running, while Il6 −/− mice had significantly higher glycogen levels in the sedentary state (Fig. 5f ). Determination of mRNA expression of different regulators of glucose metabolism in the liver showed that IL-6 deficiency had no impact on exercise-induced expression of the genes measured, with G6pase (Fig. 6a), Irs2 (Fig. 6d) and Igfbp1 (Fig. 6e) significantly upregulated to the same extent, and Pgc-1α expression increased in wild-type and tending to increase in Il6 −/− mice (Fig. 6c) , while no significant upregulation of Pepck expression was found (Fig. 6b) . PEPCK protein levels were also not influenced by the 60 min treadmill run (data not shown). Interestingly, IL-6 plasma levels were increased after running in the wildtype mice, accompanied by increased Il6 and Socs3 expression in the liver (Fig. 6f-h ). However, Socs3 was also induced in the livers of Il6 −/− mice, indicating the existence of additional exercise-related inducers of Socs3 expression (Fig. 6h) . Leptin plasma levels were not increased by exercise in either of the genotypes studied (data not shown). We also studied phosphorylation of STAT3 in the liver of sedentary and exercised wild-type and Il6 −/− mice, but the inter-individual variance was high and did not allow reliable interpretation of potential differences induced by exercise (data not shown).
Effect of IL-6 deficiency on glucose tolerance The higher insulin and glucose levels in sedentary fed Il6 −/− mice might have been caused by altered insulin sensitivity in these animals. After an i.p. glucose challenge, neither glucose (Fig. 7a, b ) nor insulin levels (data not shown) differed between Il6 −/− and wild-type mice. After an i.p.
insulin challenge Il6 −/− mice had slightly higher glucose levels than wild-type counterparts (Fig. 7c, d ).
Discussion
In this study we investigated the hypothesis that IL-6 might stimulate hepatic gluconeogenesis and, using IL-6-deficient mice, tested the physiological relevance of IL-6 for fastingand exercise-induced hepatic glucose production. IL-6 was found to be a myokine that is produced within the contracting muscle fibres [21] and released into the circulation depending on intensity and duration of exercise [22, 23] . Further research revealed that IL-6 fulfils some criteria of an exercise factor, because it stimulates glucose uptake [24, 25] and fatty acid oxidation in skeletal muscle [26, 27] , increases lipolysis [28] and activates AMP-activated protein kinase [29] . Moreover, infusion of IL-6 in humans suggested that IL-6 could enhance endogenous glucose production during prolonged exercise [17] or increase hepatic glucose output [14] . This putative ability of IL-6 to increase hepatic glucose production is further supported by data of the present study, since incubation of rat hepatoma cells with IL-6 increased glucose production from lactate and acute application of IL-6 in mice increased hepatic Pepck mRNA expression, with no significant effect on G6pase mRNA content. A similar IL-6-dependent gene regulation of Pepck and G6pase was recently reported for rat livers [30] .
In contrast to these direct effects of IL-6 administration, the lack of IL-6 in Il6 −/− mice did not seem to reduce hepatic glucose output during moderately intense exercise or fasting, nor was the upregulation of metabolic regulators of glucose metabolism impaired in both conditions. These results suggest that IL-6 is not essential for hepatic glucose production during an overnight fast or a 60 min treadmill run in mice. Interestingly, the exercise conditions used in our study are sufficient to induce IL-6 production. We found 11.4±4.4 pg/ml IL-6 in the exercised wild-type mice (compared with 7.3± 1.8 pg/ml in sedentary mice). Since we have also observed enhanced phosphorylation of STAT3 in the working muscles of wild-type, but not of Il6 −/− mice (C. Weigert, unpublished data), we conclude that skeletal muscle is the source of the IL-6 protein found in the circulation. Interestingly, we detected slightly enhanced Il6 mRNA expression in liver tissue of wild-type mice after exercise, which could be due to a self-stimulatory effect of IL-6 on its own expression [31] . Expression of Socs3, however, was increased to a similar degree after running in wild-type and Il6 −/− mice, suggesting that other stimulatory mechanisms during exercise also lead to enhanced Socs3 mRNA in the liver. It is possible that the importance of IL-6 for stimulation of glycogenolysis and gluconeogenesis in mice during physical exercise might only become evident with increasing intensity and duration of exercise. In a recent study when rats ran till exhaustion (average time on treadmill 123 min at 22 m/min and 5°inclination), IL-6 plasma levels were increased above 120 pg/ml immediately after running, accompanied by a strong increase in hepatic STAT3 phosphorylation and pronounced upregulation of G6pase, Pepck and Pgc-1α [30] . Our running conditions resulted only in a slight elevation of IL-6 plasma concentrations, with less pronounced upregulation of hepatic Pgc-1α expression, and no increase in hepatic Pepck mRNA content immediately after the run. Therefore if IL-6-deficient mice were forced to run till exhaustion, it is possible that lack of IL-6 would result in impaired adaptation of hepatic glucose metabolism to intense and prolonged exercise. However, more rigorous exercise conditions could also lead to hepatic tissue damage and infiltration of inflammatory cells [32] , which could stimulate IL-6 production in intrahepatic cells and induce IL-6-mediated tissue repair mechanisms [33] . Il6 −/− mice have defective liver repair mechanisms and blunted induction of genes involved in cell cycle progression, liver growth and maintenance of metabolic homeostasis, including gluconeogenetic enzyme genes and Igfbp1 after partial hepatectomy [11, 34, 35] . It is therefore essential to avoid exhaustive exercise conditions if distinction between metabolic and tissue repair effects of IL-6 is to be made. The mice in our exercise study showed a clear response to a metabolic challenge and the need for hepatic glucose production, since hepatic glycogen was almost completely depleted and the insulin/glucagon ratio dropped significantly. This exercise-induced metabolic stress for the liver was further reflected by the pronounced upregulation of G6pa-se, Irs2 and Igfbp1 expression, genes known to be regulated by the metabolic state of the liver [36, 37] . Moreover, using an exercise protocol with similar intensity and duration, we have recently reported the acute regulation of genes important for glucose and fatty acid metabolism in the liver of wild-type mice [38] . Thus we conclude that our moderately intense exercise regimen has strong effects on hepatic glucose metabolism, but IL-6 is not needed for activation of the hepatic response needed to counteract the decrease in plasma glucose levels. Moreover, the data suggest that the reduced endurance capacity found in Il6 −/− mice [18] could not be attributed to impaired hepatic glucose production during exercise.
While the IL-6-deficiency had no apparent effect on the variables of hepatic glucose metabolism determined in the fasting state or after moderate intense exercise, fed and sedentary Il6 −/− mice did have a mild metabolic alteration compared with wild-type mice. They had slightly higher plasma glucose levels in the fed state and also higher hepatic PEPCK protein levels. This could be due to the recently discovered role of hepatic IL-6 and STAT3 in suppression of gluconeogenesis. Thus it has been shown that insulin action in the hypothalamus activates IL-6 production in non-parenchymal intrahepatic cells, leading to STAT3 activation and suppression of Pepck and G6pase expression, a cascade interrupted in Il6 −/− mice [39, 40] .
Thus the higher plasma glucose concentrations and hepatic PEPCK protein levels could reflect impaired suppression of hepatic gluconeogenesis in fed Il6 −/− mice. Moreover, Il6
−/− mice tended to have higher plasma insulin levels in the nonfasting state (difference non-significant in fed group, significant in sedentary group), which could be secondary to the slightly higher glucose concentrations. While these higher insulin levels are not able to overcome the impaired suppression of gluconeogenesis due to the lack of IL-6, they might lead to the lower NEFA concentrations seen in the non-fasted state due to better suppression of lipolysis and higher hepatic glycogen levels. Moreover, Il6 −/− mice have a markedly higher insulin/glucagon ratio in the non-fasting state, which could be due not only to higher insulin levels, but also to the lacking effect of IL-6 on pancreatic alpha cells and glucagon secretion, which presumably results in slightly lower glucagon levels, although alpha and beta cell mass are not different under chow-fed conditions [41] . The higher insulin levels in Il6 −/− mice in the fed state might also be secondary to mild insulin resistance in these animals. The glucose tolerance test did not reveal differences compared with wild-type mice, a finding well in line with earlier reports [41, 42] , but the higher glucose levels found during the insulin challenge under non-fasting conditions might again be explained by the impaired suppression of gluconeogenesis. Since in mice IL-6 deficiency does not result in enhanced insulin sensitivity or prevent development of insulin resistance after feeding a high-fat diet [41] [42] [43] , our data obtained with Il6 −/− mice do not support the notion that IL-6 is an important mediator of insulin resistance in mice. Human studies have implicated increased circulating IL-6 levels in the development of insulin resistance [44] [45] [46] , but this remains a matter of great debate [47] .
In conclusion, a mild metabolic phenotype of Il6 −/− mice became evident in non-fasting conditions and could be explained by impaired suppression of hepatic gluconeogenesis. However, this metabolic alteration had no apparent influence on glucose metabolism after an overnight fast. Thus, the data indicate that in mice IL-6 plays a role in suppression of gluconeogenesis and is important for induction of genes involved in the regulation of glucose homeostasis during hepatic tissue repair. However, IL-6 is not necessary for glucose production during non-exhaustive exercise.
